127 related articles for article (PubMed ID: 6262480)
1. Metabolism of [3H]benzoyl-phenylalanyl-alanyl-proline by pulmonary angiotensin converting enzyme in vivo: effects of bradykinin, SQ 14225 or acute hypoxia.
Catravas JD; Gillis CN
J Pharmacol Exp Ther; 1981 May; 217(2):263-70. PubMed ID: 6262480
[No Abstract] [Full Text] [Related]
2. Kinetics of captopril- and enalapril-induced inhibition of pulmonary angiotensin converting enzyme in vivo.
Moalli R; Howell RE; Gillis CN
J Pharmacol Exp Ther; 1985 Aug; 234(2):372-7. PubMed ID: 2991497
[TBL] [Abstract][Full Text] [Related]
3. Correlation between lung and plasma angiotensin converting enzyme and the hypotensive effect of captopril in conscious rabbits.
Chen X; Pitt BR; Moalli R; Gillis CN
J Pharmacol Exp Ther; 1984 Jun; 229(3):649-53. PubMed ID: 6327968
[TBL] [Abstract][Full Text] [Related]
4. Apparent kinetics of angiotensin converting enzyme: hydrolysis of [3H]benzoyl-phenylalanyl-alanyl-proline in the isolated perfused lung.
Ashton JH; Pitt BR; Gillis CN
J Pharmacol Exp Ther; 1985 Mar; 232(3):602-7. PubMed ID: 2983065
[TBL] [Abstract][Full Text] [Related]
5. Potentiation of the algogenic action of bradykinin by an inhibitor of angiotensin I converting enzyme, captopril (SQ 14,225).
Nakano T; Taira N
Jpn J Pharmacol; 1979 Aug; 29(4):563-71. PubMed ID: 231702
[No Abstract] [Full Text] [Related]
6. The effects of pathophysiologic state on the metabolism of vasoactive peptides by mammalian lung.
Stalcup SA; Leuenberger P; Greenbaum LM; Mellins RB; Turino GM
Bull Eur Physiopathol Respir; 1979; 15(5):1031-44. PubMed ID: 228783
[TBL] [Abstract][Full Text] [Related]
7. Carboxyl-terminal tripeptidyl hydrolysis of substance P by purified rabbit lung angiotensin-converting enzyme and the potentiation of substance P activity in vivo by captopril and MK-422.
Cascieri MA; Bull HG; Mumford RA; Patchett AA; Thornberry NA; Liang T
Mol Pharmacol; 1984 Mar; 25(2):287-93. PubMed ID: 6199659
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin converting enzyme in health and disease.
Leuenberger P; Stalcup SA
Curr Probl Clin Biochem; 1983; 13():99-107. PubMed ID: 6317291
[No Abstract] [Full Text] [Related]
9. Induction of angiotensin I-converting enzyme rat lung with Captopril (SQ 14225).
Fyhrquist F; Forslund T; Tikkanen I; Grönhagen-Riska C
Eur J Pharmacol; 1980 Oct; 67(4):473-5. PubMed ID: 6256177
[TBL] [Abstract][Full Text] [Related]
10. Modulation of converting enzyme activity by hypoxia and its physiological effects.
Stalcup SA; Lipset JS; Mellins RB
Ciba Found Symp; 1980; 78():293-311. PubMed ID: 6258882
[TBL] [Abstract][Full Text] [Related]
11. [3H]Captopril binding to membrane associated angiotensin converting enzyme.
Strittmatter SM; Kapiloff MS; Snyder SH
Biochem Biophys Res Commun; 1983 May; 112(3):1027-33. PubMed ID: 6303332
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of pulmonary angiotensin-converting enzyme and 5'-nucleotidase in vivo.
Catravas JD; White RE
J Appl Physiol Respir Environ Exerc Physiol; 1984 Oct; 57(4):1173-81. PubMed ID: 6094404
[TBL] [Abstract][Full Text] [Related]
13. Analysis of rabbit pulmonary angiotensin converting enzyme kinetics in vivo.
Howell RE; Moalli R; Gillis CN
J Pharmacol Exp Ther; 1984 Jan; 228(1):154-60. PubMed ID: 6319666
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin converting enzyme and hypoxia.
Milledge JS
Bull Eur Physiopathol Respir; 1984; 20(6):481-5. PubMed ID: 6097325
[No Abstract] [Full Text] [Related]
15. Effects of alveolar pressure on lung angiotensin-converting enzyme function in vivo.
Toivonen HJ; Catravas JD
J Appl Physiol (1985); 1986 Sep; 61(3):1041-50. PubMed ID: 3019988
[TBL] [Abstract][Full Text] [Related]
16. Plasma protein binding and endothelial enzyme interactions in the lung.
Linehan JH; Dawson CA; Bongard RD; Bronikowski TA; Roerig DL
J Appl Physiol (1985); 1989 Jun; 66(6):2617-28. PubMed ID: 2545661
[TBL] [Abstract][Full Text] [Related]
17. The effects of captopril (SQ 14,225) on bradykinin-induced bronchoconstriction in the anesthetized guinea pig.
Greenberg R; Osman GH; O'Keefe EH; Antonaccio MJ
Eur J Pharmacol; 1979 Aug; 57(4):287-94. PubMed ID: 385332
[TBL] [Abstract][Full Text] [Related]
18. Effects of converting enzyme inhibitors on renin-angiotensin system in normal rats.
Komori T; Takada T; Funae Y; Yamamoto K
Osaka City Med J; 1984 Jun; 30(1):17-30. PubMed ID: 6096787
[No Abstract] [Full Text] [Related]
19. Pharmacological properties of the new non-sulfhydryl angiotensin converting enzyme inhibitor N-[8-amino-1(S)-carboxyoctyl]-L-alanyl-L-proline.
Shirota M; Kajiwara Y; Iijima M; Kitabatake K
Arzneimittelforschung; 1990 May; 40(5):515-9. PubMed ID: 2166521
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia preadaptation prevents oxygen-induced depression of lung angiotensin-converting enzyme activity.
Jackson RM; Pisarello JB
Am Rev Respir Dis; 1984 Sep; 130(3):424-8. PubMed ID: 6089627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
